| Literature DB >> 33504019 |
Cristina Panisi1,2, Franca Rosa Guerini3, Provvidenza Maria Abruzzo4, Federico Balzola5, Pier Mario Biava6, Alessandra Bolotta4, Marco Brunero7, Ernesto Burgio8, Alberto Chiara9, Mario Clerici3,10, Luigi Croce11, Carla Ferreri12, Niccolò Giovannini13, Alessandro Ghezzo4, Enzo Grossi14, Roberto Keller15, Andrea Manzotti16, Marina Marini4, Lucia Migliore17, Lucio Moderato1, Davide Moscone18, Michele Mussap19, Antonia Parmeggiani20, Valentina Pasin21, Monica Perotti22, Cristina Piras23, Marina Saresella3, Andrea Stoccoro17, Tiziana Toso24, Rosa Anna Vacca25, David Vagni26, Salvatore Vendemmia27, Laura Villa28, Pierluigi Politi2, Vassilios Fanos19,29.
Abstract
The wide spectrum of unique needs and strengths of Autism Spectrum Disorders (ASD) is a challenge for the worldwide healthcare system. With the plethora of information from research, a common thread is required to conceptualize an exhaustive pathogenetic paradigm. The epidemiological and clinical findings in ASD cannot be explained by the traditional linear genetic model, hence the need to move towards a more fluid conception, integrating genetics, environment, and epigenetics as a whole. The embryo-fetal period and the first two years of life (the so-called 'First 1000 Days') are the crucial time window for neurodevelopment. In particular, the interplay and the vicious loop between immune activation, gut dysbiosis, and mitochondrial impairment/oxidative stress significantly affects neurodevelopment during pregnancy and undermines the health of ASD people throughout life. Consequently, the most effective intervention in ASD is expected by primary prevention aimed at pregnancy and at early control of the main effector molecular pathways. We will reason here on a comprehensive and exhaustive pathogenetic paradigm in ASD, viewed not just as a theoretical issue, but as a tool to provide suggestions for effective preventive strategies and personalized, dynamic (from womb to adulthood), systemic, and interdisciplinary healthcare approach.Entities:
Keywords: Autism Spectrum Disorder (ASD); epigenetics; gut dysbiosis; immune activation; machine learning; metabolomics; mitochondrial impairment; oxidative stress; pathogenesis; prevention
Year: 2021 PMID: 33504019 PMCID: PMC7912683 DOI: 10.3390/jpm11020070
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426